Ethics and equity in access to disease‐modifying therapies and newborn screening for spinal muscular atrophy: A scoping review

Serini Murugasen, Mariana Kruger, Marc Blockman, Jo M. Wilmshurst

Open source

DOI
10.1111/dmcn.70297
Published
2026-04-30
Container
Developmental Medicine & Child Neurology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dmcn.70297,
  title = {Ethics and equity in access to disease‐modifying therapies and newborn screening for spinal muscular atrophy: A scoping review},
  author = {Serini Murugasen and Mariana Kruger and Marc Blockman and Jo M. Wilmshurst},
  year = {2026},
  journal = {Developmental Medicine \& Child Neurology},
  doi = {10.1111/dmcn.70297},
  url = {https://doi.org/10.1111/dmcn.70297}
}

RIS

TY  - JOUR
TI  - Ethics and equity in access to disease‐modifying therapies and newborn screening for spinal muscular atrophy: A scoping review
AU  - Serini Murugasen
AU  - Mariana Kruger
AU  - Marc Blockman
AU  - Jo M. Wilmshurst
PY  - 2026
JO  - Developmental Medicine & Child Neurology
DO  - 10.1111/dmcn.70297
UR  - https://doi.org/10.1111/dmcn.70297
ER  - 

APA

Murugasen, S., Kruger, M., Blockman, M., & Wilmshurst, J. M. (2026). Ethics and equity in access to disease‐modifying therapies and newborn screening for spinal muscular atrophy: A scoping review. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70297

Source records